SPDR S&P Biotech ETF XBI
$151.19−3.28% today
3:59 PM ET
10.8% below its one-year high of $169.55 (Aug 19).
$151.19 · Nov 12, 2026 · +32.49% over 1 year
$169.55$140.73$111.91
Nov 12, 2025May 15, 2026Nov 12, 2026
- Previous close
- $156.31
- 1 week
- +1.88%
- 1 month
- +2.99%
- Year to date
- +24.00%
- 1 year
- +32.49%
- Expense ratio
- 0.35%
- a year, of assets
- Fund assets
- $10.9B
- Yield
- 0.35%
- Fund family
- State Street Investment Management
- Category
- Health
1-year range
$111.91 low · Nov 13Aug 19 · high $169.55
Top holdings
18.1% of the fund- 01MRNAModerna Inc2.37%
- 02NTRANatera Inc1.82%
- 03HALOHalozyme Therapeutics Inc1.77%
- 04TWSTTwist Bioscience Corp1.77%
- 05BIIBBiogen Inc1.75%
- 06AMGNAmgen Inc1.73%
- 07EXELExelixis Inc1.73%
- 08UTHRUnited Therapeutics Corp1.72%
- 09ABBVAbbVie Inc1.71%
- 10GILDGilead Sciences Inc1.70%
Weights as the fund last reported them · 4:12 PM ET
Sector mix
- healthcare99.3%
- financial services0.7%
More etfs
All 15 →ARKKARK Innovation ETF1Y$76.46−2.56%SOXXiShares Semiconductor ETF1Y$154.99−0.26%IGViShares Expanded Tech-Software ETF1Y$101.47−0.74%BOTZGlobal X Robotics & Artificial Intelligence ETF1Y$31.42−2.51%CIBRFirst Trust Nasdaq Cybersecurity ETF1Y$96.46+0.22%KRESPDR S&P Regional Banking ETF1Y$72.52−0.59%
4:00 PM ET
Public data, may be delayed. Not investment advice.